We found that MYCN downregulation by siRNA leads to neuroblastoma differentiation as measured by morphological changes and NF-L-expressing neurite outgrowth (Supplementary Fig. 9), which may indicate that differentiated cells should have lower MYCN levels. This evidence concerns the gene MYCN and neuroblastoma.